proteomics
Proteomics
Sera Prognostics Q3 Revenues Drop 31 Percent, Firm Begins Consumer-Initiated Preterm Birth Testing
The firm said on Wednesday that it has been hiring key sales and marketing personnel as it prepares to ramp up sales in 2025 of its PreTRM proteomic test.
PamGene, Alithea Genomics, Lausanne University get €1M for Pan-Cancer Blood Test
The Dutch-Swiss Mainline consortium plans to develop a multiomics model to guide immune checkpoint inhibitor therapy across a broad range of cancers.
The firm is working on more assays to help decide which cancer patients are suitable for immunotherapies and hopes to establish a US-based lab in 2023.
OncoHost Raises $35M in Series C Financing
The Israeli firm will use the funds to expand its PROPHETIC trial and support the US commercial launch of the Prophet platform.
Bio-Techne Fiscal Q3 Revenues Rise 19 Percent
The company's Diagnostics and Genomics segment revenues were up 34 percent, while its Protein Sciences segment revenues grew 15 percent.